Transforming growth factor-β-induced lncRNA-Smad7 inhibits apoptosis of mouse breast cancer JygMC(A) cells

Cancer Science

Volumn 105, Issue 8, 2014, Pages 974-982

  Arase, Mayu ^a   Horiguchi, Kana ^a,d   Ehata, Shogo ^a   Morikawa, Masato ^b   Tsutsumi, Shuichi ^c   Aburatani, Hiroyuki ^c   Miyazono, Kohei ^a,b   Koinuma, Daizo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^c UNIVERSITY OF TOKYO   (Japan)

^d CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Apoptosis; Breast cancer; Long non coding RNA; Smad7; Transforming growth factor

Indexed keywords

LONG UNTRANSLATED RNA; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA3; SMAD7 PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE LOCUS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RNA SEQUENCE; SIGNAL TRANSDUCTION;

APOPTOSIS; BREAST CANCER; LONG NON-CODING RNA; SMAD7; TRANSFORMING GROWTH FACTOR-Β;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BLOTTING, NORTHERN; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOPRECIPITATION; LYMPHOTOXIN-ALPHA; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; RNA, SMALL INTERFERING; SMAD7 PROTEIN;

EID: 84906935688     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12454     Document Type: Article

References (32)

1. Happo L, Strasser A, Cory S. BH3-only proteins in apoptosis at a glance. J Cell Sci 2012; 125: 1081-7.
2. Roberts AB, Wakefield LM. The two faces of transforming growth factor-β in carcinogenesis. Proc Natl Acad Sci USA 2003; 100: 8621-3.
3. Miyazono K, Ehata S, Koinuma D. Tumor-promoting functions of transforming growth factor-β in progression of cancer. Ups J Med Sci 2012; 117: 143-52.
4. Ehata S, Hanyu A, Hayashi M et al. Transforming growth factor-β promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. Cancer Res 2007; 67: 9694-703.
5. Hoshino Y, Katsuno Y, Ehata S, Miyazono K. Autocrine TGF-β protects breast cancer cells from apoptosis through reduction of BH3-only protein, Bim. J Biochem 2011; 149: 55-65.
6. Gadir N, Jackson DN, Lee E, Foster DA. Defective TGF-β signaling sensitizes human cancer cells to rapamycin. Oncogene 2008; 27: 1055-62.
7. Okazaki Y, Furuno M, Kasukawa T et al. Analysis of the mouse transcriptome based on functional annotation of 60, 770 full-length cDNAs. Nature 2002; 420: 563-73.
8. Chen LL, Carmichael GG. Decoding the function of nuclear long non-coding RNAs. Curr Opin Cell Biol 2010; 22: 357-64.
9. Bartolomei MS, Zemel S, Tilghman SM. Parental imprinting of the mouse H19 gene. Nature 1991; 351: 153-5.
10. Gupta RA, Shah N, Wang KC et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-6.
11. Yan B, Wang Z. Long noncoding RNA: its physiological and pathological roles. DNA Cell Biol 2012; 31(Suppl. 1): S34-41.
12. Serpico D, Molino L, Di Cosimo S. MicroRNAs in breast cancer development and treatment. Cancer Treat Rev 2014; 40: 595-604.
13. Mizutani A, Saitoh M, Imamura T, Miyazawa K, Miyazono K. Arkadia complexes with clathrin adaptor AP2 and regulates EGF signalling. J Biochem 2010; 148: 733-41.
14. Guttman M, Donaghey J, Carey BW et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 2011; 477: 295-300.
15. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013; 14: R36.
16. Trapnell C, Roberts A, Goff L et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 2012; 7: 562-78.
17. Shirakihara T, Saitoh M, Miyazono K. Differential regulation of epithelial and mesenchymal markers by δEF1 proteins in epithelial mesenchymal transition induced by TGF-β. Mol Biol Cell 2007; 18: 3533-44.
18. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012; 9: 703-19.
19. Chu C, Qu K, Zhong FL, Artandi SE, Chang HY. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell 2011; 44: 667-78.
20. Nie Y, Liu X, Qu S, Song E, Zou H, Gong C. Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci 2013; 104: 458-64.
21. Ge XS, Ma HJ, Zheng XH et al. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway. Cancer Sci 2013; 104: 1675-82.
22. Zhang A, Zhou N, Huang J et al. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res 2013; 23: 340-50.
23. Wang Y, Xu Z, Jiang J et al. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell 2013; 25: 69-80.
24. Wan G, Hu X, Liu Y et al. A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation. EMBO J 2013; 32: 2833-47.
25. Hu P, Yang J, Hou Y et al. LncRNA expression signatures of twist-induced epithelial-to-mesenchymal transition in MCF10A cells. Cell Signal 2014; 26: 83-93.
26. Hong S, Kim HY, Kim J et al. Smad7 protein induces interferon regulatory factor 1-dependent transcriptional activation of caspase 8 to restore tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis. J Biol Chem 2013; 288: 3560-70.
27. Zhang Y, Handley D, Kaplan T et al. High throughput determination of TGF-β1/SMAD3 targets in A549 lung epithelial cells. PLoS ONE 2011; 6: e20319.
28. Mizutani A, Koinuma D, Tsutsumi S et al. Cell type-specific target selection by combinatorial binding of Smad2/3 proteins and hepatocyte nuclear factor 4α in HepG2 cells. J Biol Chem 2011; 286: 29848-60.
29. Kennedy BA, Deatherage DE, Gu F et al. ChIP-seq defined genome-wide map of TGF-β/SMAD4 targets: implications with clinical outcome of ovarian cancer. PLoS ONE 2011; 6: e22606.
30. Qin H, Chan MW, Liyanarachchi S et al. An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules. BMC Syst Biol 2009; 3: 73.
31. Morikawa M, Koinuma D, Miyazono K, Heldin CH. Genome-wide mechanisms of Smad binding. Oncogene 2013; 32: 1609-15.
32. Zhou Q, Chung AC, Huang XR, Dong Y, Yu X, Lan HY. Identification of novel long noncoding RNAs associated with TGF-β/Smad3-mediated renal inflammation and fibrosis by RNA sequencing. Am J Pathol 2014; 184: 409-17.